Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2025-12-25 @ 5:00 AM
NCT ID: NCT00105118
Eligibility Criteria: INCLUSION CRITERIA: 1\. Male and Female subjects, age 18-55 EXCLUSION CRITERIA: 1. Significant psychiatric, or severe chronic medical illness at the time of the study, or by history. This criterion includes the absence of substance abuse histories, learning disabilities or any other DSM-IV AXIS I or II disorder with documented cognitive impairment. The P.I. or his designate will evaluate medical histories. Medical conditions that are judged not to interfere with the study may be allowed. 2. Pregnancy, personal or family history of epilepsy, concurrent use of tricyclic antidepressants, neuroleptic agents, or any licit or illicit drugs that could lower the seizure threshold, or history of complicated migraine. 3. Persons with surgically or traumatically implanted ferro-magnetic objects in the head that may pose a physical hazard during magnetic stimulation will also be excluded. 4. Use of psychotropic substances in the last 3 months. 5. Head injury with a period of more than 15 minutes unconsciousness, or head trauma with any duration loss of consciousness in the last year, or any evidence of functional impairment due to and persisting after head trauma. 6. Use of caffeine or tobacco in the 2 hours preceding the test. 7. Subjects who have been previously excluded from NIH MRI or TMS protocols for safety reasons. 8. Subjects who are found to have eye lesions on exam. 9. First degree relative with a history of cognitive disorder with onset before age 55 by subject report, and by collateral report of at least one other family member, if necessary.
Healthy Volunteers: True
Sex: ALL
Study: NCT00105118
Study Brief:
Protocol Section: NCT00105118